Clinical Trials Directory

Trials / Completed

CompletedNCT03238547

Screening of Microalbuminuria Using a Semi-quantitative UACR Test

Accuracy of a Semi-quantitative Urine Albumin-to-creatinine Ratio Test as a Screening Tool for Microalbuminuria in Patients With Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Microalbuminuria is an important biomarker for the development of diabetic nephropathy and cardiovascular complications. Since microalbuminuria is not easily detected on routine urinalysis, current guidelines recommend measuring spot urine albumin-to-creatinine ratio (uACR) annually in a patient with diabetes mellitus. While the standard method is quantitative measurement using turbidimetric immunoassay, it requires high cost and special laboratory equipment. This may be a hurdle that prevents screening for microalbuminuria in many patients with diabetes. Therefore, a semi-quantitative uACR test, which is rapid and inexpensive, could be used as a substitute to the current standard quantitative measurement. The investigators aimed to assess the diagnostic accuracy of a semi-quantitative urine albumin-to-creatinine ratio test, URiSCAN 2ACR, as a screening tool for microalbuminuria in patients with diabetes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTsemi-quantitative urine albumin-to-creatinine ratio testmeasurement of urine albumin-to-creatinine ratio using URiSCAN 2ACR, a semi-quantitative urine albumin-to-creatinine ratio test
DIAGNOSTIC_TESTstandard quantitative spot urine albumin-to-creatinine ratiomeasurement of urine albumin-to-creatinine ratio using a standard turbidimetric immunoassay

Timeline

Start date
2017-08-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-08-03
Last updated
2020-03-25

Locations

1 site across 1 country: South Korea

Regulatory

Source: ClinicalTrials.gov record NCT03238547. Inclusion in this directory is not an endorsement.